Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells

Cytokine

Volumn 61, Issue 1, 2013, Pages 173-180

  Jiang, Cheng Gang ^a   Lv, Ling ^a   Liu, Fu Rong ^a   Wang, Zhen Ning ^a   Na, Di ^a   Li, Feng ^a   Li, Jia Bin ^a   Sun, Zhe ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell adhesion; Connective tissue growth factor; Epithelial mesenchymal transition; Human peritoneal mesothelial cells; Stomach neoplasms

Indexed keywords

BETA CATENIN; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER GROWTH; CELL SHAPE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; WESTERN BLOTTING;

ACTINS; BETA CATENIN; CADHERINS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE PROGRESSION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; HUMANS; PERITONEAL CAVITY; PERITONEUM; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

EID: 84869865765     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.013     Document Type: Article

References (41)

1. Shimoyama S., Seto Y., Yasuda H., et al. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution. World J Surg 2005, 29:58-65.
2. Lindsey H. Preoperative chemoradiotherapy shows promise in gastric cancer. Lancet Oncol 2004, 5:519.
3. Siegel R., Ward E., Brawley O., et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
4. Jiang C.G., Xu Y., Wang Z.N., et al. Clinicopathological analysis and prognostic significance of peritoneal cytology in chinese patients with advanced gastric cancer. ANZ J Surg 2011, 81:608-613.
5. McMorrow T., Gaffney M.M., Slattery C., et al. Cyclosporine a induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol Dial Transplant 2005, 20:2215-2225.
6. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
7. Chien W., Yin D., Gui D., et al. Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells. Mol Cancer Res 2006, 4:591-598.
8. Lau L.F., Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999, 248:44-57.
9. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 2001, 54:57-79.
10. Brigstock D.R. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999, 20:189-206.
11. Li M.H., Sanchez T., Pappalardo A., et al. Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res 2008, 6:1649-1656.
12. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784.
13. Perbal B. CCN proteins multifunctional signalling regulators. Lancet 2004, 363:62-64.
14. Sako A., Kitayama J., Koyama H., et al. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. Cancer Res 2004, 64:3624-3628.
15. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
16. van Kessel K.P., Park C.T., Wright S.D. A fluorescence microassay for the quantitation of integrin-mediated adhesion of neutrophil. J Immunol Methods 1994, 172:25-31.
17. Inoki I., Shiomi T., Hashimoto G., et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 2002, 16:219-221.
18. Shimo T., Nakanishi T., Nishida T., et al. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 2001, 61:315-322.
19. Zeng Z.J., Yang L.Y., Ding X., et al. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World J Gastroenterol 2004, 10:3414-3418.
20. Kang Y., Siegel P.M., Shu W., et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
21. Dornhöfer N., Spong S., Bennewith K., et al. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2006, 66:5816-5827.
22. Bennewith K.L., Huang X., Ham C.M., et al. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 2009, 69:775-784.
23. Yang F., Tuxhorn J.A., Ressler S.J., et al. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 2005, 65:8887-8895.
24. Xie D., Yin D., Wang H.J., et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004, 10:2072-2081.
25. Xie D., Nakachi K., Wang H., et al. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001, 61:8917-8923.
26. Jiang C.G., Lv L., Liu F.R., et al. Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination. Mol Cancer 2011, 10:122.
27. Sala-Torra O., Gundacker H.M., Stirewalt D.L., et al. Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia. Blood 2007, 109:3080-3083.
28. Wong Y.F., Cheung T.H., Tsao G.S., et al. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 2006, 118:2461-2469.
29. Deng Y.Z., Chen P.P., Wang Y., et al. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J Biol Chem 2007, 282:36571-36581.
30. Chang C.C., Shih J.Y., Jeng Y.M., et al. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 2004, 96:364-375.
31. Lin B.R., Chang C.C., Che T.F., et al. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology 2005, 128:9-23.
32. Neilson E.G. Mechanisms of disease: Fibroblasts - a new look at an old problem. Nat Clin Pract Nephrol 2006, 2:101-108.
33. Akhurst R.J., Derynck R. TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol 2001, 11:S44-S51.
34. Elliott R.L., Blobe G.C. Role of transforming growth factor Beta in human cancer. J Clin Oncol 2005, 23:2078-2093.
35. Marek A., Brodzicki J., Liberek A., et al. TGF-beta (transforming growth factor-beta) in chronic inflammatory conditions - a new diagnostic and prognostic marker?. Med Sci Monit 2002, 8:RA145-RA151.
36. Bierie B., Moses H.L. Tumour microenvironment: TGFbeta: the molecular jekyll and hyde of cancer. Nat Rev Cancer 2006, 6:506-520.
37. Derynck R., Akhurst R.J. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 2007, 9:1000-1004.
38. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
39. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
40. Ksiazek K., Mikula-Pietrasik J., Korybalska K., et al. Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin. Am J Pathol 2009, 174:1230-1240.
41. Lv Z.D., Na D., Liu F.N., et al. Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis. J Exp Clin Cancer Res 2010, 29:139.